Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Experimental Neurology
|
July 1, 1983
Effect of interruption of bulbospinal pathways on lordosis, posture, and locomotion
F P Zemlan, L M Kow, D W Pfaff
Biological Psychiatry
|
June 1, 1987
Growth hormone response to apomorphine and family patterns of illness
F Sautter, D L Garver, F P Zemlan, et al.
Psychiatry Research
|
July 1, 1986
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine
F P Zemlan, J Hirschowitz, F Sautter, et al.
Psychiatrie, Neurologie, Und Medizinische Psychologie
|
May 1, 1990
[Plasma anticholinergic activity and cognitive function in geriatric patients]
O J Thienhaus, J Thoene, A Allen, et al.
Biological Psychiatry
|
September 1, 1986
Superoxide dismutase, chromosome 21, and Alzheimer's disease
O J Thienhaus, C Cliffe, F P Zemlan, et al.
The American Journal of Psychiatry
|
November 1, 1985
Down-regulation of central dopamine receptors in schizophrenia
F P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Life Sciences
|
January 1, 1996
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease
F P Zemlan, M Keys, R W Richter, et al.
Brain Research
|
March 11, 1977
Influence of p-chloroamphetamine on female sexual reflexes and brain monoamine levels
F P Zemlan, M E Trulson, R Howell, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1983
Thioridazine effect on desipramine plasma levels
J Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophrenia
F P Zemlan, J Hirschowitz, F J Sautter, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Experimental Neurology
|
July 1, 1983
Effect of interruption of bulbospinal pathways on lordosis, posture, and locomotion
F P Zemlan, L M Kow, D W Pfaff
Biological Psychiatry
|
June 1, 1987
Growth hormone response to apomorphine and family patterns of illness
F Sautter, D L Garver, F P Zemlan, et al.
Psychiatry Research
|
July 1, 1986
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine
F P Zemlan, J Hirschowitz, F Sautter, et al.
Psychiatrie, Neurologie, Und Medizinische Psychologie
|
May 1, 1990
[Plasma anticholinergic activity and cognitive function in geriatric patients]
O J Thienhaus, J Thoene, A Allen, et al.
Biological Psychiatry
|
September 1, 1986
Superoxide dismutase, chromosome 21, and Alzheimer's disease
O J Thienhaus, C Cliffe, F P Zemlan, et al.
The American Journal of Psychiatry
|
November 1, 1985
Down-regulation of central dopamine receptors in schizophrenia
F P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Life Sciences
|
January 1, 1996
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease
F P Zemlan, M Keys, R W Richter, et al.
Brain Research
|
March 11, 1977
Influence of p-chloroamphetamine on female sexual reflexes and brain monoamine levels
F P Zemlan, M E Trulson, R Howell, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1983
Thioridazine effect on desipramine plasma levels
J Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophrenia
F P Zemlan, J Hirschowitz, F J Sautter, et al.
Page
of 8